Literature DB >> 8132635

Heterologous expression of human prostatic acid phosphatase and site-directed mutagenesis of the enzyme active site.

K Ostanin1, A Saeed, R L Van Etten.   

Abstract

Earlier covalent modification experiments indicated that histidine, arginine, and carboxylic acid residues were involved in the catalytic mechanism of the acid phosphatase enzyme from human prostate. The present study utilizes site-directed mutagenesis to evaluate the catalytic importance of 7 residues of human prostatic phosphatase, namely His12, His257, Asp258, Arg11, Arg15, Arg54, and Arg79, which are highly conserved in the sequences of high molecular weight acid phosphatases. Both wild type and mutant enzymes were expressed in the yeast Saccharomyces cerevisiae as fusions to a leader peptide of prepro-alpha-factor, which resulted in the secretion of processed proteins into the culture media. The kinetic parameters of the recombinant wild type enzyme were shown to be effectively identical with those of the native protein. The circular dichroism spectra of wild type and mutant proteins were effectively superimposable. Replacement of His12, which was previously shown to be transiently phosphorylated during catalysis, as well as the adjacent Arg11, both resulted in > 10(4) reductions of enzyme activity. Consistent with a postulated involvement of arginine residues in substrate binding, large reductions in Vmax caused by the R15A and R79A mutations were accompanied by marked increases in Km. However, the mutation R54A had only small effects on kinetic parameters. Essential roles for both His257 and Asp258 were also established. The D258A mutation not only caused larger decreases of Vmax toward p-nitrophenyl phosphate compared to the effect of the H257A mutation, but it also caused the reaction to become more sensitive to the nature of the leaving group. It is concluded that His12 and Asp258 are involved in the formation of the phosphoenzyme intermediate as an acceptor of the phospho group and a proton donor for the substrate leaving group, respectively, while His257 may participate in substrate binding or may facilitate the breakdown of the phosphoenzyme by maintaining the protonated state of the phosphorylated His12 residue.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132635

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Identification of a novel phosphatase sequence motif.

Authors:  J Stukey; G M Carman
Journal:  Protein Sci       Date:  1997-02       Impact factor: 6.725

2.  From phosphatases to vanadium peroxidases: a similar architecture of the active site.

Authors:  W Hemrika; R Renirie; H L Dekker; P Barnett; R Wever
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

3.  Crystal structures and biochemical studies of human lysophosphatidic acid phosphatase type 6.

Authors:  Jun Li; Yu Dong; Xingru Lü; Lu Wang; Wei Peng; Xuejun C Zhang; Zihe Rao
Journal:  Protein Cell       Date:  2013-06-26       Impact factor: 14.870

4.  Prostatic acid phosphatase reduces thermal sensitivity and chronic pain sensitization by depleting phosphatidylinositol 4,5-bisphosphate.

Authors:  Nathaniel A Sowa; Sarah E Street; Pirkko Vihko; Mark J Zylka
Journal:  J Neurosci       Date:  2010-08-04       Impact factor: 6.167

5.  A cofactor-dependent phosphoglycerate mutase homolog from Bacillus stearothermophilus is actually a broad specificity phosphatase.

Authors:  D J Rigden; I Bagyan; E Lamani; P Setlow; M J Jedrzejas
Journal:  Protein Sci       Date:  2001-09       Impact factor: 6.725

6.  Molecular cloning and expression of a rat hepatic multiple inositol polyphosphate phosphatase.

Authors:  A Craxton; J J Caffrey; W Burkhart; S T Safrany; S B Shears
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

7.  Crystal Structures of the histidine acid phosphatase from Francisella tularensis provide insight into substrate recognition.

Authors:  Harkewal Singh; Richard L Felts; Jonathan P Schuermann; Thomas J Reilly; John J Tanner
Journal:  J Mol Biol       Date:  2009-10-21       Impact factor: 5.469

Review 8.  Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor.

Authors:  Sakthivel Muniyan; Matthew A Ingersoll; Surinder K Batra; Ming-Fong Lin
Journal:  Biochim Biophys Acta       Date:  2014-04-18

9.  Acid phosphatases do not contribute to the pathogenesis of type A Francisella tularensis.

Authors:  Robert Child; Tara D Wehrly; Dedeke Rockx-Brouwer; David W Dorward; Jean Celli
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

10.  Recombinant mouse PAP has pH-dependent ectonucleotidase activity and acts through A(1)-adenosine receptors to mediate antinociception.

Authors:  Nathaniel A Sowa; Kunjumon I Vadakkan; Mark J Zylka
Journal:  PLoS One       Date:  2009-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.